Skip to main content

Pfizer, BioNTech opens 2nd phase of tests for COVID-19 vaccine in kids under 12

Pharma company Pfizer said Tuesday it will begin testing the effectiveness of its COVID-19 vaccine in larger groups of children 11 and younger.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.